Not sure how the math adds up, but CMS estimates that the 52% cut to the 88305 TC will only result in a 6% decrease in pathology reimbursement.
CAP 13 Fee Schedule Comments Aim to Curb Reimbursement Cuts; Protect Pathologists Role in Molecular Pathology
The College urged the Centers for Medicare and Medicaid Services (CMS) to make changes that would prevent some of the cuts in reimbursement to pathology scheduled for 2013 as well as strengthen the pathologists role in molecular pathology in its response to the agencys final 2013 physician fee schedule rule.
For 2013, CMS estimates that reimbursement to pathologists will decrease 6% primarily due to cuts in the technical component (TC) and global payment for CPT code 88305. CAPs comments also respond to the agencys request for additional evidence regarding the appropriate number of blocks assumed for capturing technical component costs for certain anatomic pathology services.